NCT00178945View on ClinicalTrials.gov

Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

March 31, 2006

Conditions

Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS)Cervical Dystonia

Interventions

DRUG

Botulinum Toxin Type A

Trial Locations (1)

37212

Vanderbilt Department of Neurology, Nashville

All Listed Sponsors

lead

Vanderbilt University

OTHER

NCT00178945 - Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain | Biotech Hunter | Biotech Hunter